SCHEMBL7862785

SCHEMBL7862785

COc1ccc(Cl)c(C(=O)NCCc2ccc(S(=O)(=O)NC(=O)c3ccc(OC(=O)O)nc3)cc2)c1

nearest known ligand 0.53

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.52
KMT2A Q03164 2/20 0.51
MEN1 O00255 1/20 0.51
ALDH1A1 P00352 2/20 0.51
SMN1; SMN2 Q16637 2/20 0.51
MAPT P10636 1/20 0.51
HTT P42858 1/20 0.50
NLRP3 Q96P20 2/20 0.47
P4HTM Q9NXG6 1/20 0.46
CA12 O43570 1/20 0.45
CA1 P00915 1/20 0.45
CA2 P00918 1/20 0.45
CA9 Q16790 1/20 0.45
RAB9A P51151 1/20 0.44
FLT1 P17948 1/20 0.43
FLT4 P35916 1/20 0.43
KDR P35968 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7871643 0.93 KMT2A (0.51) LMNAKMT2AMEN1ALDH1A1SMN1; SMN2
SCHEMBL9018558 0.91 ALDH1A1 (0.48) LMNAKMT2AMEN1ALDH1A1SMN1; SMN2
SCHEMBL7867892 0.91 KMT2A (0.50) LMNAKMT2AMEN1ALDH1A1SMN1; SMN2
SCHEMBL7867898 0.91 KMT2A (0.50) LMNAKMT2AMEN1ALDH1A1SMN1; SMN2
SCHEMBL9018425 0.90 KMT2A (0.47) LMNAKMT2AMEN1ALDH1A1SMN1; SMN2
SCHEMBL9018112 0.89 LMNA (0.51) LMNAKMT2AMEN1ALDH1A1SMN1; SMN2
SCHEMBL8869039 0.89 LMNA (0.53) LMNAKMT2AMEN1ALDH1A1SMN1; SMN2
SCHEMBL9018184 0.89 ALDH1A1 (0.46) LMNAKMT2AMEN1ALDH1A1SMN1; SMN2
SCHEMBL7871602 0.89 KMT2A (0.48) LMNAKMT2AMEN1ALDH1A1SMN1; SMN2
SCHEMBL9018156 0.88 ALDH1A1 (0.46) LMNAKMT2AMEN1ALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0562512-B1 Sulfonamidocarbonylpyridine-2-carboxamides and their use as medicines HOECHST AG (DE) 2001-02-21 EP disclosed
EP-0590520-B1 Acylsulphonamido and sulphonamidopyridine-2-carboxylic acid esters, pyridine-n-oxides thereof, a process for their preparation and their use as medicaments HOECHST AG (DE) 1996-06-12 EP disclosed
EP-0590520-A1 Acylsulphonamido and sulphonamidopyridine-2-carboxylic acid esters, pyridine-n-oxides thereof, a process for their preparation and their use as medicaments HOECHST AKTIENGESELLSCHAFT (DE) 1994-04-06 EP disclosed
EP-0562512-A1 Sulfonamido- and sulfonamidocarbonyl-pyridine-2-carboxamides and their pyridine-N-oxides, process for their preparation and their use as medicines HOECHST AKTIENGESELLSCHAFT (DE) 1993-09-29 EP disclosed